<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02766062</url>
  </required_header>
  <id_info>
    <org_study_id>NZ1651</org_study_id>
    <nct_id>NCT02766062</nct_id>
  </id_info>
  <brief_title>Effects of Propofol and Sevoflurane on Early POCD in Elderly Patients With Metabolic Syndrome</brief_title>
  <official_title>Effects of Propofol and Sevoflurane on Early Postoperative Cognitive Dysfunction in Elderly Patients With Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>General Hospital of Ningxia Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>General Hospital of Ningxia Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate propofol versus sevoflurane anesthesia on the
      effects of early postoperative cognitive function in elderly patients with metabolic
      syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      By now, a series risk factors of cardiovascular diseases, which are also related to the
      development of postoperative cognitive dysfunction (POCD), are becoming more common.The
      investigators don't know whether propofol based anesthesia has a more severe impact on early
      postoperative cognitive function than sevoflurane in elderly patients with metabolic
      syndrome. In this study, the investigators want to investigate propofol versus sevoflurane
      anesthesia on the effects of early postoperative cognitive function in elderly patients with
      metabolic syndrome.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with Postoperative cognitive dysfunction (POCD) as assessed by Mini-Mental State Examination (MMSE) score in propofol group and sevoflurane group</measure>
    <time_frame>up to 7days postoperatively</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">94</enrollment>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>propofol group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with metabolic syndrome were randomly assigned to receive propofol anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with metabolic syndrome were randomly assigned to receive sevoflurane anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>metabolic syndrome</intervention_name>
    <description>metabolic syndrome</description>
    <arm_group_label>propofol group</arm_group_label>
    <arm_group_label>sevoflurane group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged ≥60 years;

          -  ASAⅡor Ⅲ

          -  noncardiac surgery and nonneural surgery

        Exclusion Criteria:

          -  Mini Mental State Examination [MMSE] score too low

          -  chronic alcoho and drug abuse

          -  disturbed renal and liver function

          -  history of a cerebrovascular accident

          -  permanent ventricular pacing

          -  preoperative cognitive deficits

          -  lack of cooperation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 1, 2016</study_first_submitted>
  <study_first_submitted_qc>May 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 9, 2016</study_first_posted>
  <last_update_submitted>June 29, 2016</last_update_submitted>
  <last_update_submitted_qc>June 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Postoperative cognitive dysfunction</keyword>
  <keyword>metabolic syndrome</keyword>
  <keyword>propofol</keyword>
  <keyword>sevoflurane</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>safety</ipd_description>
  </patient_data>
  <pending_results>
    <submitted>July 12, 2016</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>August 4, 2016</submitted>
    <returned>September 21, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

